Jogo Health

Insmed Incorporated is a biopharmaceutical company focused on development and commercialization of drug formulations for treatment of metabolic diseases and endocrine disorders. The company, located in Glen Allen, Va., focuses on correcting metabolic defects in human body by replacing key proteins physiologically. It develops drugs that modulate insulin-like growth factor-1 activity in human body. Insmed Incorporated offers various drug candidates, such as recombinant human IGF-1 bound to protein-3, and IPLEX, which is mecasermin rinfabate injection for treatment of growth failure in children with severe IGF-I deficiency. The company also offers anti-cancer drugs, such as recombinant human insulin-like growth factor binding protein-3, and INSM-18. It develops drugs to treat indications in metabolic and oncology fields.

Bordoloi Biotech LLC, located in Bridgewater, NJ, specializes in the development and marketing of innovative health products, including their unique HerboCare™ cream. This topical Ayurvedic solution is formulated with natural herbal ingredients aimed at alleviating muscle soreness and fatigue, making it ideal for active individuals. The company emphasizes the efficacy of its products through rigorous pharmacological trials, demonstrating the potential benefits of their formulations in managing pain and inflammation. With a commitment to quality, Bordoloi Biotech collaborates with both U.S. and Indian manufacturers to ensure the highest standards in production. Generated from the website

Neurotez, based in Bridgewater Twp, NJ, is a biotechnology company dedicated to becoming a global leader in the development of innovative solutions for brain disorders. With a focus on central nervous system (CNS) drugs, their integrated platform spans from discovery to proof of concept clinical trials, aiming to deliver safe and efficacious treatments. Committed to excellence and responsible service to the public, Neurotez aims to transform the lives of individuals affected by conditions such as Alzheimer's disease and dementia. Driven by a team of exceptional talent and capabilities, Neurotez utilizes biochemical, molecular cell biology, and in vivo models to screen, identify, and characterize suitable candidate drugs for Alzheimer's disease. Recognizing the intricate metabolic pathways underlying the pathology of Alzheimer's, the company leverages genetic, epidemiological, and in vitro studies to develop groundbreaking therapeutic approaches. With a vision to cure Alzheimer's disease and improve the understanding of aging-related cognitive decline, Neurotez is poised to make significant contributions in the field of neuroscience.Generated from the website